GENFIT - GNFT.PA 

BIOTECH & PHARMA
2,524,043 Shares Currently Shorted 2,524,043 Shares Currently Shorted (Adjusted)
Insider Positions - Sale: 32.26€/ Buy: 36.63€
Days to Cover
2 2
Set up an alert on GENFIT !     Check out shorts in the BIOTECH & PHARMA sector!

Historical short positions

Short positions indicators - stock market 9

Shorter (Click on a funds name to get more insight!)
Current Percentage
Trend
Effective Date
MILLENNIUM INTERNATIONAL MANAGEMENT
0.48 %
0.49, 0.50, 0.39, 0.51, 0.48
2019-06-17
WORLDQUANT
0.65 %
0.68, 0.55, 0.47, 0.54, 0.65
2019-06-17
BLACKROCK INSTITUTIONAL TRUST
1.01 %
0.84, 0.72, 0.83, 0.94, 1.01
2019-06-14
VOLEON CAPITAL MANAGEMENT LP
0.91 %
0.59, 0.60, 0.70, 0.80, 0.91
2019-06-14
POINT72 ASSET MANAGEMENT LP
0.53 %
Only one filing.
2019-06-12
CITADEL ADVISORS LLC
1.14 %
1.02, 1.10, 1.20, 1.32, 1.14
2019-06-11
HIGHBRIDGE CAPITAL MANAGEMENT LLC
0.69 %
1.03, 0.95, 0.89, 0.79, 0.69
2019-05-29
MARSHALL WACE LLP
0.64 %
0.95, 0.89, 0.79, 0.81, 0.64
2019-03-29
BNP PARIBAS
0.45 %
0.61, 0.54, 0.47, 0.50, 0.45
2019-01-04

Shortics - Insider trading data and indicatorsInsider Trading Activity

Average Price - Sale: 32.26€/ Buy: 36.63€

Shortics - Short positions and days to cover indicatorsLatest Insider positions

SAS BIOTECH AVENIR SAS
2017-12-14
Membre du Conseil dAdministration
Acquisition
£ 1,849,992
Jean-François MOUNEY
2017-10-24
Président Directeur Général
Acquisition
£ 42,504
Jean-François MOUNEY
2015-06-15
Président du Directoire
Acquisition
£ 101,160
Jean-François MOUNEY
2015-04-27
Président du Directoire
Acquisition
£ 201,070
SAS BIOTECH AVENIR
2014-11-04
Membre du Conseil de Surveillance
Cession
£ 20,778,000
SAS BIOTECH AVENIR
2014-10-01
Membre du Conseil de Surveillance
Cession
£ 6,062,463
SAS BIOTECH AVENIR
2014-07-23
Membre du Conseil de Surveillance
Cession
£ 12,589,500
Jean-François MOUNEY
2014-07-17
Président du Directoire
Cession
£ 146,000
INSTITUT PASTEUR DE LILLE
2014-04-14
Membre du Conseil de surveillance
Cession
£ 3,898
INSTITUT PASTEUR DE LILLE
2014-04-11
Membre du Conseil de surveillance
Cession
£ 377,488